Preclinical development of a molecular clamp‐stabilised subunit vaccine for severe acute respiratory syndrome coronavirus 2Daniel Watterson, Keith J. Chappell, Koert J. Stittelaar et al.|Clinical & Translational Immunology|2021Cited by 62
Development of Novel Activin-Targeted TherapeuticsJustin L. Chen, Craig A. Harrison, Kelly L. Walton et al.|Molecular Therapy|2014Cited by 57
Activin A–Induced Cachectic Wasting Is Attenuated by Systemic Delivery of Its Cognate Propeptide in Male MiceKelly L. Walton, Craig A. Harrison, Justin L. Chen et al.|Endocrinology|2019Cited by 22
Molecular clamp stabilised Spike protein for protection against SARS-CoV-2Daniel Watterson, Keith J. Chappell, Danushka K. Wijesundara et al.|Unknown|2020Cited by 15
Rapid Application of the Molecular Clamp Platform for SARS-CoV-2Daniel Watterson, Keith J. Chappell, Danushka K. Wijesundara et al.|SSRN Electronic Journal|2020Cited by 1